Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence
about
Trial Watch: Peptide-based anticancer vaccines.Classification of current anticancer immunotherapiesTrial watch: Naked and vectored DNA-based anticancer vaccinesActivity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivoInhibition of tumor growth and metastasis by EMMPRIN multiple antigenic peptide (MAP) vaccination is mediated by immune modulation.Surface engineering tumor cells with adjuvant-loaded particles for use as cancer vaccines.RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses.Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies.Targeted chemo-immunotherapy of leukemia.The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma
P2860
Q34483345-E6F0FD75-2E27-4C58-A9A6-ADA6FE94FA52Q35149637-7D08BAEC-1CFA-406D-972C-F5156460748AQ35798986-219837B3-3026-46F5-A592-95A98E90FB37Q37072087-7F6BC37A-98A6-4000-B2FA-20FC16E9BF92Q38716487-BA85F297-4B39-48F5-8598-5F537E6E1584Q39037485-41EC7D3A-C44E-4525-8426-D4E502EE4641Q41450925-F15FB63D-E5D0-4382-8E87-3AE202D30087Q46193557-E4B0A67D-BA8A-4A05-AE2C-D68C7075A52FQ47221163-DEA86B5B-B55D-42B3-9897-1F0F463A8F99Q48308048-04238B47-E77D-4708-9D7F-363C2F695902Q51053221-66F0E63A-AB78-4F84-A331-727D124577E4Q58788254-7FC4DD58-E427-42CA-B13D-26BCD3B91DBA
P2860
Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence
@ast
Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence
@en
type
label
Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence
@ast
Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence
@en
prefLabel
Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence
@ast
Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence
@en
P2860
P356
P1476
Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence
@en
P2093
Brian M Olson
P2860
P304
P356
10.1586/ERV.12.107
P577
2012-11-01T00:00:00Z